Preventing Hypoxia in Sedated TAVI: SuperNO₂VA vs. Conventional Oxygen

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07006064

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Ankara Bilkent Sehir Hastanesi (from the registry)
Registry
  • NCT NCT07006064
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07006064. Randomized; quadruple masking; primary purpose treatment. Start 2025-05-15 (actual); primary completion 2026-01-25 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Preventing Hypoxia in Sedated TAVI: SuperNO₂VA vs. Conventional Oxygen
Condition
Aortic Stenosis
Intervention (Device)
SUPERNOVA
Intervention (Device)
NASAL MASK
Lead sponsor
Ankara Bilkent Sehir Hastanesi (class: other)

Record details

Record id
cardio:ct-nct07006064
Content hash
56f14a89483d29d879875cb53b4d996ccc82e1b49d12986ee5e30fcfd14eb590